New York Cancer Consortium is a clinical research site located in The Bronx, New York, United States 10461.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
New York Cancer Consortium has participated in 1 clinical trials.
Therapeutic areas: Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer.
Sponsors: National Cancer Institute (NCI).
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New York Cancer Consortium has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New York Cancer Consortium has 1 clinical trials on record. Their work covers Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer.
New York Cancer Consortium has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.